Yiran Gan 4/8/25 Yiran Gan 4/8/25 Theoretical Explorations of Reductions in The Alternative-current Magnetic Susceptibility of Reagent in Immunomagnetic Reduction Assay Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Biomarker Assessment in Parkinson’s Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical Measures Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 White matter alterations and their associations with biomarkers and behavior in subjective cognitive decline individuals: a fixel-based analysis Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 The Ratio of Plasma Amyloid-β 1-42 over Serum Albumin Can Be a Novel Biomarker Signature for Diagnosing End-Stage Renal Disease-Associated Cognitive Impairment Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Thickness, Annealing, and Surface Roughness Effect on Magnetic and Significant Properties of Co40Fe40B10Dy10 Thin Films Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Studying the Effects of Annealing and Surface Roughness on Both the Magnetic Property and Surface Energy of Co60Fe20Sm20 Thin Films on Si(100) Substrate Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Analyzer-to-Analyzer Variations in Assaying Ultralow Concentrated Biomarkers Associated with Neurodegenerative Diseases Using Immunomagnetic Reduction Read More Newer Posts Older Posts
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Theoretical Explorations of Reductions in The Alternative-current Magnetic Susceptibility of Reagent in Immunomagnetic Reduction Assay Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Biomarker Assessment in Parkinson’s Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical Measures Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 White matter alterations and their associations with biomarkers and behavior in subjective cognitive decline individuals: a fixel-based analysis Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 The Ratio of Plasma Amyloid-β 1-42 over Serum Albumin Can Be a Novel Biomarker Signature for Diagnosing End-Stage Renal Disease-Associated Cognitive Impairment Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Thickness, Annealing, and Surface Roughness Effect on Magnetic and Significant Properties of Co40Fe40B10Dy10 Thin Films Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Studying the Effects of Annealing and Surface Roughness on Both the Magnetic Property and Surface Energy of Co60Fe20Sm20 Thin Films on Si(100) Substrate Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Analyzer-to-Analyzer Variations in Assaying Ultralow Concentrated Biomarkers Associated with Neurodegenerative Diseases Using Immunomagnetic Reduction Read More
